Epidemiology of diabetes and its treatment in the Lombardy Region between 2000 and 2007 [Dalla lettura dei database amministrativi: L'epidemiologia e il trattamento del diabete in Regione Lombardia dal 2000 al 2007]
Monesi L.,Laboratorio Of Ricerca In Medicina Generale |
Baviera M.,Laboratorio Of Ricerca In Medicina Generale |
Cortesi L.,Laboratorio Of Ricerca In Medicina Generale |
Marzona I.,Laboratorio Of Ricerca In Medicina Generale |
And 10 more authors.
Giornale Italiano di Diabetologia e Metabolismo | Year: 2012
Epidemiology of diabetes and its treatment in the Lombardy Region between 2000 and 2007: administrative database figures Diabetes is constantly increasing worldwide and is one of the most burdensome and costly chronic conditions. Administrative health databases are an important tool in public health surveillance for defining the burden of diseases, health service planning and the appropriate allocation of resources. The data on the entire cohort of diabetic subjects residing in the Lombardy Region show that the prevalence of the disease rose by 4% yearly from 2000 to 2007. Our estimates suggest that the increase will continue over the next decade, reaching 11.1% in 2030 in people aged ≥ 30 years. The incidence remained stable during the study period and overall mortality declined yearly by 3%. The proportions of patients treated with biguanides rose while those receiving sulfonylureas dropped. The proportions of patients treated with the newer classes of drugs (glinides and glitazones) increased slightly but steadily and these were more frequently prescribed in association with other anti-diabetic drugs. The progressive rise in cardiovascular drug prescriptions indicates a sharper focus on prevention of cardiovascular complications in diabetes. However, in 2007 only one out of five of these patients received ACE-inhibitors, lipid-lowering and antiplatelet drugs, so there is ample room for improvement. Considering the probable increase in the numbers of diabetic patients in coming years, cardiovascular prevention should be assigned a more important role in managing complications. Source